Fundraising Fox
/Companies
Sign in

Etiome

Founded 2021 · 26 employees on LinkedIn · 1 known investors

Find your way into Etiome

Each arrow is one introduction. Sign up to fill in the first one.

1,448 people can intro you to Noubar

Ask Brian Baynes to introduce you to Noubar Afeyan

You →Brian · together at Kaleido Biosciences, Inc. →Noubar

975 people can intro you to Scott

Ask Jamie Chen to introduce you to Scott Lipnick

You →Jamie · together at The New York Stem Cell Foundation →Scott

327 people can intro you to Artem

Ask Sam Okafor to introduce you to Artem Sokolov

You →Sam · together at University of California, Santa Cruz →Artem

Sign up to find every way you can get introduced to Etiome

  • Your email: who you already know at Etiome, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Etiome team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Etiome develops stage-specific medicines by applying single-cell omics and artificial intelligence to map disease progression and identify disease-modifying targets at early biological inflection points for preemptive intervention. Founded in 2021 out of Flagship Pioneering's Preemptive Health and Medicine initiative, the biotech company focuses on treating or reversing disease before it advances to later stages.

AI & Machine LearningBiotechLongevity

Founders & leadership

KVKatharine von Herrmann
Katharine von HerrmannCo-founder
AKAvak Kahvejian
Avak KahvejianFounding Team; Founding CEOAvak Kahvejian is founding CEO of Etiome, a biotech company developing stage-specific medicines using single-cell omics and AI to identify disease-modifying targets. He previously worked at Flagship Pioneering, where he conceived and launched platform companies focused on novel biological mechanisms and biotechnologies.
NANoubar Afeyan
Noubar AfeyanFounding TeamInvestor at Flagship Pioneering
SLScott Lipnick
Scott LipnickFounding TeamScott Lipnick is a member of the founding team at Etiome, a biotech company developing stage-specific medicines using single-cell omics and AI to identify disease-modifying targets for early intervention. He previously worked at Flagship Pioneering, where he collaborated on the Preemptive Health and Medicine initiative and co-founded multiple companies focused on preemptive health approaches.
TSTorben Straight Nissen
Torben Straight NissenFounding Team; Board DirectorExecutive Officer, Director at Rubius Therapeutics
YEYann Echelard
Yann EchelardFounding Team; Chief Operating Officer
ARAdrian Rawcliffe
Adrian RawcliffeCEO-Partner & Chief Executive Officer
JL
Jean LachowiczChief Scientific Officer
SE
Sandi EngleHead of Biology
ASArtem Sokolov
Artem SokolovHead of Computational BiologyArtem Sokolov is Head of Computational Biology at Etiome, a biotech company developing stage-specific medicines through single-cell omics and artificial intelligence to identify early disease intervention targets. His research background spans computational biology and disease modeling, as evidenced by his scholarly publications and software development work.

Investors · 1

Founder mafia

2 people who came through Etiome went on to found or lead other companies.

Noubar AfeyanFounding TeamFounded ProFound Therapeutics +15Avak KahvejianFounding Team; Founding CEOFounded ProFound Therapeutics +5

In the news

Etiome Steps Out of Stealth With $50M to Address Disease At The 'Silent Stage' - BioSpacebiospace.com · Apr 2025

Frequently asked questions

What does Etiome do?
Etiome develops stage-specific medicines by applying single-cell omics and artificial intelligence to map disease progression and identify disease-modifying targets at early biological inflection points for preemptive intervention. Founded in 2021 out of Flagship Pioneering's Preemptive Health and Medicine initiative, the biotech company focuses on treating or reversing disease before it advances to later stages.
Who founded Etiome?
Etiome was founded by Katharine von Herrmann, Avak Kahvejian, Noubar Afeyan, Scott Lipnick, Torben Straight Nissen, Yann Echelard in 2021.
Who are Etiome's investors?
Etiome's investors include Flagship Pioneering.